fludarabine has been researched along with Lymphoma, Large-Cell, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Fukano, R; Fukuda, T; Hashii, Y; Inagaki, J; Inoue, M; Kato, K; Kobayashi, R; Maseki, N; Mitsui, T; Mori, T; Okada, K; Sato, A; Shimoyama, T; Shindo, M; Suzuki, R; Suzumiya, J; Tabuchi, K | 1 |
| Fujita, N; Fukano, R; Hashimoto, H; Kada, A; Kamei, M; Kobayashi, R; Koga, Y; Mitsui, T; Mori, T; Ohki, K; Osumi, T; Saito, AM; Sekimizu, M; Tanaka, F; Ueyama, J | 1 |
| Aker, M; Brautbar, C; Nagler, A; Naparstek, E; Or, R; Slavin, S; Varadi, G | 1 |
1 trial(s) available for fludarabine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Melphalan; Transplantation Conditioning; Vidarabine | 2020 |
2 other study(ies) available for fludarabine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Busulfan; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Melphalan; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2019 |
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cell Count; Child; Cohort Studies; Disease-Free Survival; Female; Graft Survival; Histocompatibility; Humans; Leukemia; Life Tables; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |